Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Rook

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Investigative Dermatology|July 1, 1992
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cellsB R Vowels, M Cassin, E C Vonderheid, et al.
Clinical and Experimental Immunology|November 1, 1982
Natural killer cells and interferon responses in patients with systemic lupus erythematosusG C Tsokos, A H Rook, J Y Djeu, et al.
Infection|July 1, 1984
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
Transfusion|September 1, 1986
Red cell autoantibodies in patients with acquired immune deficiency syndromeM H McGinniss, A M Macher, A H Rook, et al.
Infection|January 1, 1985
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|November 1, 1994
Use of extracorporeal photochemotherapy in heart transplant recipients during acute rejection: a case studyW H Macey, B DeNardo, A H Rook, et al.
Dermatologic Clinics|April 1, 1993
Therapeutic applications of photopheresisA H Rook, J H Cohen, S R Lessin, et al.
Artificial Organs|December 1, 1994
Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejectionJ T Wolfe, S R Lessin, A H Singh, et al.
Archives of Dermatology|April 1, 1993
The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cellsA H Rook, B R Vowels, C Jaworsky, et al.
Journal of the American Academy of Dermatology|May 1, 1995
De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphomaJ T Wolfe, A Singh, S R Lessin, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|July 1, 1992
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cellsB R Vowels, M Cassin, E C Vonderheid, et al.
Clinical and Experimental Immunology|November 1, 1982
Natural killer cells and interferon responses in patients with systemic lupus erythematosusG C Tsokos, A H Rook, J Y Djeu, et al.
Infection|July 1, 1984
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
Transfusion|September 1, 1986
Red cell autoantibodies in patients with acquired immune deficiency syndromeM H McGinniss, A M Macher, A H Rook, et al.
Infection|January 1, 1985
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|November 1, 1994
Use of extracorporeal photochemotherapy in heart transplant recipients during acute rejection: a case studyW H Macey, B DeNardo, A H Rook, et al.
Dermatologic Clinics|April 1, 1993
Therapeutic applications of photopheresisA H Rook, J H Cohen, S R Lessin, et al.
Artificial Organs|December 1, 1994
Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejectionJ T Wolfe, S R Lessin, A H Singh, et al.
Archives of Dermatology|April 1, 1993
The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cellsA H Rook, B R Vowels, C Jaworsky, et al.
Journal of the American Academy of Dermatology|May 1, 1995
De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphomaJ T Wolfe, A Singh, S R Lessin, et al.
Pageof 12